InsidersTradesSigma
Total declarations
Company
▲ Purchases (22 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
22
Disclosed sells
0
T+90 hit rate
5%
T+90 mean return
-39.3%
Across 19 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Sullivan James David, Directeur Juridique. Director active across 1 company, notably BIO KEY International INC. In total, 37 reports have been published. Split: 22 buys · 0 sell. Total volume traded: €88k. Activity tracked since 20 May 2021. The latest transaction was filed on 31 December 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Sullivan James David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations37 total
250 sharesCommon StockSEC:0001437749-26-022527:0
2,500 shares@ US$0.461.0% of flowCommon StockSEC:0001437749-26-000379:0
40,000 shares0Common StockSEC:0001437749-25-028295:0
10,000 shares@ US$0.775.3% of flowCommon StockSEC:0001437749-25-027787:0
Canonical exit: 20 Nov 2025 (T+90)
139 shares@ US$0.700.1% of flowCommon StockSEC:0001437749-25-022020:0
139 shares@ US$1.400.1% of flowCommon StockSEC:0001437749-25-000211:0
22,500 shares0Common StockSEC:0001437749-24-024509:0
139 shares@ US$1.3940.1% of flowCommon StockSEC:0001437749-24-022006:0
139 shares@ US$2.550.3% of flowCommon StockSEC:0001437749-24-000423:0
20,000 shares@ US$0.1652.4% of flowCommon StockSEC:0001437749-23-033447:0
Canonical exit: 28 Feb 2024 (T+90)
17,609 shares@ US$0.1652.1% of flowCommon StockSEC:0001437749-23-033092:1
Canonical exit: 22 Feb 2024 (T+90)
959 shares@ US$0.1730.1% of flowCommon StockSEC:0001437749-23-033092:2
Canonical exit: 22 Feb 2024 (T+90)
1,100 shares@ US$0.17310.1% of flowCommon StockSEC:0001437749-23-033092:3
Canonical exit: 22 Feb 2024 (T+90)
9,803 shares@ US$0.1641.2% of flowCommon StockSEC:0001437749-23-033092:4
Canonical exit: 25 Feb 2024 (T+90)
100 shares@ US$0.180.0% of flowCommon StockSEC:0001437749-23-033092:5
Canonical exit: 25 Feb 2024 (T+90)
100 shares@ US$0.17990.0% of flowCommon StockSEC:0001437749-23-033092:6
Canonical exit: 25 Feb 2024 (T+90)
10,000 shares@ US$0.161.2% of flowCommon StockSEC:0001437749-23-033092:0
Canonical exit: 22 Feb 2024 (T+90)
228,000 shares@ US$0.17530.2% of flowCommon StockSEC:0001437749-23-029811:0
Canonical exit: 28 Jan 2024 (T+90)
96 shares@ US$0.530.0% of flowCommon StockSEC:0001437749-23-026164:0
Canonical exit: 14 Dec 2023 (T+90)
1,200 shares@ US$0.520.5% of flowCommon StockSEC:0001437749-23-025634:0
Canonical exit: 10 Dec 2023 (T+90)
3,800 shares@ US$0.531.5% of flowCommon StockSEC:0001437749-23-025634:1
Canonical exit: 10 Dec 2023 (T+90)
4,000 shares@ US$0.5281.6% of flowCommon StockSEC:0001437749-23-025634:2
Canonical exit: 10 Dec 2023 (T+90)
5,000 shares@ US$0.552.0% of flowCommon StockSEC:0001437749-23-025190:0
Canonical exit: 29 Nov 2023 (T+90)
30,000 shares0Common StockSEC:0001437749-23-024954:0
2,500 shares@ US$0.49730.9% of flowCommon StockSEC:0001437749-23-019332:0
25 of 37 declarations
About Sullivan James David
Sullivan James David is Directeur Juridique and Chief Legal Officer at BIO KEY International INC, on XNAS. He has 37 filings in total, and among the recent filings observed between 2021-05-21 and 2026-07-02, buys total EUR 87955 and sells EUR 0, with the dominant transaction nature indicated as Acquisition.
